IMS Health Adopts Amazon Web Services to Expand Deployment Options, Increase Scalability of IMS One, Nexxus Commercial Application Suite

IMS Health (NYSE:IMS), the global provider of healthcare information and technology solutions, announced the decision to host its Software-as-a-Service commercial applications on Amazon Web Services (AWS). Through the AWS global footprint, IMS Health will offer life sciences organizations additional options for deploying and scaling the Nexxus™ Commercial Application Suite and IMS One™ intelligent cloud — providing fast, reliable and secure access to integrated sales and marketing information across critical commercial functions.

In life sciences operations, where new commercial launch trajectories are established quickly and traditionally difficult to optimize, speed and agility are critical. IMS Health’s cloud solutions give customers the ability to monitor and adjust their sales and marketing operations supported by comprehensive analytics produced by the company’s applications.

With seamlessly interoperable Software-as-a-Service applications spanning critical commercial functions, the Nexxus Commercial Application Suite rapidly aligns, tracks and guides sales engagement and brand strategies across multiple channels. The Nexxus Suite includes applications for integrated, multi-channel marketing campaign management, CRM, social media vigilance and cross-company analytics, and business intelligence and key performance indicator tools. The IMS One intelligent cloud integrates IMS Health’s critical life sciences data with client and third-party information sources, creating a single, trusted view easily accessible by the Nexxus applications—dramatically enhancing commercial effectiveness while reducing complexity and costs.

“Our hosting on AWS answers the growing customer need for flexible and accessible cloud solutions backed by IMS Health’s deep understanding of local markets and global information security practices,” said Sati Sian, senior vice president, Global Technology & Operations, IMS Health. “By delivering our leading healthcare information, technology and services through the largest and most trusted provider of cloud infrastructure, we’re providing the innovative solutions companies need to deploy commercial healthcare applications faster, and with lower overhead.”

“With the AWS Cloud, IMS Health provides its healthcare customers with solutions that measure and improve their performance by putting valuable healthcare data from a wide range of sources into action to improve patient care,” said Adam Selipsky, vice president, Amazon Web Services, Inc. “Taking advantage of AWS’s rich platform, operational excellence and rapid pace of innovation, IMS Health is able to focus all of its energy on creating amazing solutions for its customers in the government, pharmaceutical, consumer health, and medical device industries – and leave the undifferentiated heavy lifting of managing infrastructure to us.”

About IMS Health

IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. By applying sophisticated analytics and proprietary application suites hosted on the IMS One intelligent cloud, the company connects more than 10 petabytes of complex healthcare data on diseases, treatments, costs and outcomes to help its clients run their operations more efficiently. Drawing on information from 100,000 suppliers and on insights from more than 45 billion healthcare transactions processed annually, IMS Health’s approximately 10,000 employees drive results for healthcare clients globally. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at www.imshealth.com.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.